| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
60,850,000 |
| Market
Cap: |
5.84(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$0.05 - $0.1182 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Aptinyx is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of proprietary, synthetic small molecules for the treatment of brain and nervous system disorders. Co. focuses on targeting and modulating N-methyl-D-aspartate receptors (NMDArs), which are vital to normal and effective function of the brain and nervous system. Co. is developing a pipeline of product candidates derived from its NMDAr modulator discovery platform, or the discovery platform: NYX-2925 for the treatment of chronic pain; NYX-783 for the treatment of post-traumatic stress disorder; and NYX-458 for the treatment of cognitive impairment.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-02-04 |
2023-11-03 |
2023-05-05 |
2022-05-05 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Miller Joan W. |
|
– • – |
2022-01-13 |
4 |
B |
$2.83 |
$50,091 |
D/D |
17,700 |
17,700 |
0.01 |
-80% |
|
| Riedel Norbert G |
CEO |
• • – |
2021-12-06 |
4 |
B |
$2.23 |
$223,000 |
I/I |
100,000 |
100,000 |
0.01 |
-55% |
|
| Khanna Ashish |
CFO AND CBO |
• – – |
2021-12-02 |
4 |
B |
$2.26 |
$101,700 |
D/D |
45,000 |
420,040 |
0.01 |
-54% |
|
| Hombach Robert J. |
|
– • – |
2021-11-12 |
4/A |
B |
$2.40 |
$179,040 |
D/D |
74,600 |
229,100 |
0.01 |
- |
|
| Hombach Robert J. |
|
– • – |
2021-11-12 |
4 |
B |
$2.40 |
$179,040 |
D/D |
74,600 |
219,100 |
0.01 |
- |
|
| Hombach Robert J. |
|
– • – |
2021-11-11 |
4/A |
B |
$2.40 |
$12,960 |
D/D |
5,400 |
154,500 |
0.01 |
- |
|
| Hombach Robert J. |
|
– • – |
2021-11-11 |
4 |
B |
$2.40 |
$12,960 |
D/D |
5,400 |
144,500 |
0.01 |
12% |
|
| Khanna Ashish |
CFO AND CBO |
• – – |
2021-05-17 |
4 |
D |
$2.53 |
$96,368 |
D/D |
(38,090) |
375,040 |
|
- |
|
| Khanna Ashish |
CFO AND CBO |
• – – |
2021-05-17 |
4 |
OE |
$0.00 |
$0 |
D/D |
130,000 |
413,130 |
|
- |
|
| Riedel Norbert G |
CEO |
• • – |
2021-05-17 |
4 |
D |
$2.53 |
$322,003 |
D/D |
(127,274) |
615,265 |
|
- |
|
| Riedel Norbert G |
CEO |
• • – |
2021-05-17 |
4 |
OE |
$0.00 |
$0 |
D/D |
380,000 |
742,539 |
|
- |
|
| Kidd Andrew |
PRESIDENT & COO |
• – – |
2021-05-17 |
4 |
D |
$2.53 |
$96,368 |
D/D |
(38,090) |
101,043 |
|
- |
|
| Kidd Andrew |
PRESIDENT & COO |
• – – |
2021-05-17 |
4 |
OE |
$0.00 |
$0 |
D/D |
130,000 |
139,133 |
|
- |
|
| Koppel Adam |
Director |
– • • |
2020-10-26 |
4 |
B |
$3.00 |
$9,999,999 |
I/I |
3,333,333 |
8,891,758 |
2.25 |
3% |
|
| Topper James N |
Director |
– • – |
2020-03-31 |
4 |
A |
$2.16 |
$10,748 |
I/I |
4,976 |
3,195,055 |
|
- |
|
| Adams Street Partners Llc |
10% Owner |
– – • |
2020-01-29 |
4 |
A |
$0.00 |
$0 |
I/I |
90,124 |
185,120 |
|
- |
|
| Sherman Rachel E. |
Director |
– • – |
2020-01-22 |
4 |
B |
$4.79 |
$10,413 |
D/D |
2,174 |
2,174 |
2.39 |
-29% |
|
| Schwartz Jeffrey Lawrence |
10% Owner |
– – • |
2020-01-14 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
5,558,425 |
|
29% |
|
| Koppel Adam |
Director |
– • • |
2020-01-14 |
4 |
B |
$3.00 |
$9,999,999 |
I/I |
3,333,333 |
5,558,425 |
2.25 |
29% |
|
| Adams Street Partners Llc |
10% Owner |
– – • |
2020-01-10 |
4 |
B |
$3.00 |
$3,000,000 |
I/I |
1,000,000 |
1,465,716 |
1.5 |
19% |
|
| Hombach Robert J. |
Director |
– • – |
2020-01-10 |
4 |
B |
$3.00 |
$150,000 |
D/D |
50,000 |
139,100 |
2.39 |
19% |
|
| Enright Patrick G |
Director |
– • – |
2020-01-10 |
4 |
B |
$3.00 |
$500,001 |
I/I |
166,667 |
3,356,746 |
2.1 |
19% |
|
| Enright Patrick G |
Director |
– • – |
2020-01-10 |
4 |
B |
$3.00 |
$285,000 |
D/D |
95,000 |
95,000 |
2.39 |
19% |
|
| Gosebruch Henry O |
Director |
– • – |
2020-01-10 |
4 |
B |
$3.00 |
$75,000 |
I/I |
25,000 |
125,000 |
2.1 |
19% |
|
| Riedel Norbert G |
CEO and President |
• • – |
2020-01-10 |
4 |
B |
$3.00 |
$105,000 |
I/I |
35,000 |
35,000 |
2.66 |
19% |
|
69 Records found
|
|
Page 1 of 3 |
|
|
